ECCO 2021

IL23 inhibiton: Efficacy & Safety Updates

Comparing the different modes of action in IBD:…

Novel agents: Do we need new drugs or just…

Artificial Intelligence in IBD ... Even today a part of…

What are the therapeutic goals in IBD? Clinical goals…

Therapeutic algorithms: How to define? Transfering…

AI - Has artificial intelligence reached IBD

AI is coming!

Classification through AI is coming!

Künstliche Intelligenz hilfreich bei Auswertung…

AI está llegando!

L'intelligence artificielle arrive dans la RCH !

SEAVUE - Head-to-head comparison: Applicable for daily…

SEAVUE: Early intervention leads to great remission;…

SAEVUE: The 1st biologic head-to-head trial in Crohn's…

SEAVUE: no difference in remission between ustekinumab…

Which treatment for acute/severe UC after steroid…

The SEAVUE Trial - will it help us to guide and…

SEAVUE: From efficacy to pharmacoeconomic perspectives

More JAK inhibitors - same questions!

Need for early resection in Crohn's disease is not…

Adalimumab vs Ustekinumab: dai risultati di confronto…

SEAVUE: Early intervention leads to great remission;…

Enfin un seuil avec l'UCEIS !

Badanie SEAVUE - czy pomoże nam pozycjonować leki…

Leczenie chirurgiczne na bardzo wczesnym etapie choroby…

PREdiCCt: Predictive factors associated with fatigue in…

Hot topic: Intestinational ultrasound for disease…

Towards UCEIS cutoff in UC

Liquid biopsy as a novel non-invasive biomarker in IBD

Symsptoms and signs assocation - the value of histology

VARSITY: Epithelial neutrophils are very important…

Liquid biopsy opens exciting window for biomarker…

PREdiCCt: Fatigue assoziierte prädiktive Faktoren

Hot topic: Tarmultralyd til monitorering af Crohn's…

Quel traitement d'entretien en cas de colite aiguë…

IL-12/23 Blockade: Mechanism of action

New drugs with signifiicant efficacy: ritlecitinib,…

Upadacitinib: Impressive induction data in Ulcerative…

Results form phase 3 induction studies with…

Upadacitinib significantly effective in UC…

IL-23 inhibition with risankizumab effective for…

SELECTION updates: no apparent safety concerns for…

ADVANCE and MOTIVATE: Risankizumab with fast induction…

VIBRATO: Ritlecitinib and brepocitinib both effective.…

Neue Aspekte zu IL-12 und IL-23-Antikörpern

New drugs with signifiicant efficacy: ritlecitinib,…

Resultaten van de fase 3 inductie studies met…

Ritlecitinib und Brepocitinib: Neue Targets der…

Anti-IL-23 Antikörper könnten potentielle Game-changer…

5-ASA - back from the other side? New COVID-19 safety…

Immune response to anti-SARS-CoV-2 vaccinations in…

Odpowiedź immunologiczna na szczepienia przeciw…

Fecal transplantation or diet for Ulcerative Colitis?

Increasing prevalence of IBD in Brazil

CRAFT UC: Diet more effective than FMT? We need more…

My perspective on ECCO2021

Update ECCO-Guideline on Vaccination and Vaccination…

Stigende forekomst af IBD i Brasilien

Appendektomi ved patienter med colitis ulcerosa

Stoelgangstransplantatie of dieet voor colitis ulcera?

Neue ECCO-Leitlinie zu Infektionen und Impstrategie

Konditionierte Diät ist der FMT bei CU überlegen